AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule
... of the prostate, affecting more than 20 million
men in the U.S. alone.
"We are very pleased to have ... (BPH) is one of the most common diseases of aging
men - affecting more than 20 million
men in the United States - but its etiology is far ...
AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia
... of the prostate, affecting more than 20 million
men in the U.S. alone. Sanofi-aventis U.S. LLC ... (BPH) is one of the most common diseases of aging
men - affecting more than 20 million
men in the United States - but its etiology is far ...
Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting
... in combination with docetaxel and prednisone in
men with castrate-resistant prostate cancer ... presentation reported data from a cohort of
men with docetaxel-refractory prostate cancer who ... with docetaxel (D) and prednisone (P) in
men with castrate resistant prostate cancer (CRPC). ...
Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
... upregulation and peripheral immune responses in
men enrolled in the trial.
PROVENGE or placebo ... in APCs is maintained after boosting in
men with androgen-dependent prostate cancer," said ... consistent with that observed in our studies of
men with androgen-independent disease where the ...
PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
... 3 IMPACT study of PROVENGE(R) (sipuleucel-T) in
men with advanced prostate cancer met its primary ... A deno C arcinoma T reatment) study enrolled
men with metastatic androgen-independent prostate ... Dendreon's investigational product candidate for
men with advanced prostate cancer and may represent ...
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
... of the prostate, affecting more than 20 million
men in the U.S. alone.
Under the terms of the ... to market which could provide millions of
men with a novel treatment for BPH. Furthermore, this ... (BPH) is one of the most common diseases of aging
men - affecting more than 20 ...
Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
... Memorial Sloan-Kettering Cancer Center. "These
men have a limited life expectancy, and currently ... results and the large unmet medical need for
men with castration-resistant prostate cancer, I am ... common cancer worldwide. More than 1 million
men in the United States have prostate cancer. In ...
International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCool's New Investigational UroCool System
... cancer is the most common cancer in American
men other than skin cancers. One in six
men will develop prostate cancer in their lifetime, and in 2007 over 200,000
men were newly diagnosed with the disease. ...
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
... cancer is the most common cancer in American
men other than skin cancers. One in six
men will develop prostate cancer in their lifetime, and in 2007 over 200,000
men were newly diagnosed with the disease. ...
Exposure to Agent Orange linked to prostate cancer in Vietnam veterans
... form of cancer by studying a large population of
men in their 60s and the prostate-specific antigen ... that were either too small or conducted on
men who were too young, patients in the current study ... and 2006, the study revealed that twice as many
men exposed to Agent Orange were identified with ...
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
... cancer is the most
common cancer in American
men other than skin cancers. One in six
men will
develop prostate cancer in their lifetime, ... cancer grows
relatively slowly and 7 out of 10
men are diagnosed in the early stages of
the disease ...
Dendreon Reports Third Quarter 2008 Financial Results
... immunotherapy PROVENGE(R) (sipuleucel-T) in
men with metastatic androgen-independent ... * Initiated a Phase 2 trial of PROVENGE in
men with localized prostate cancer who are ... surrounding the efficacy of PROVENGE to treat
men suffering
from prostate cancer, risks and ...
AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
... and convenient treatment for the
millions of
men with BPH."
The study, titled, "Cetrorelix ... (BPH) is one of the most common diseases
of aging
men - affecting more than 20 million
men in the United States -
but its etiology is far ...
Exposure to Agent Orange linked to prostate cancer in Vietnam veterans
... form of cancer by studying a large population of
men in their 60s and the prostate-specific antigen ... that were either too small or conducted on
men who were too young, patients in the current study ... and 2006, the study revealed that twice as many
men exposed to Agent Orange were identified with ...
Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers'
... N.J., Sept. 22 /PRNewswire/ -- A new survey of
men and
women age 40 and older in the United States ... were to be applied to the total
populations of
men over 40 and women over 50 it could mean that as ... heart disease.
** Using population numbers for
men over 40 and women over 50 from the
U.S. census ...
Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
... HUNTINGTON BEACH, Calif., Sept. 5 /PRNewswire/ --
men in the Los
Angeles area who suffer from the ... )
"Too many
men suffer with the symptoms of frequent or ... offered by the LIFE(TM) procedure means that
men can
now easily treat what is one of the most ...
Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon
... EAST LONGMEADOW, Mass., Sept. 5 /PRNewswire/ --
men living in Western
Oregon who suffer from the ... )
"Too many
men suffer with the symptoms of frequent or ... Chief Operating Officer for biolitec. "Often
men are reluctant
to seek treatment, thinking the ...
Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
... common cancer worldwide. More than one million
men in
the United States have prostate cancer, with ... to be diagnosed in 2008, and approximately 28,660
men expected to
die this year from the disease. Currently there are limited treatment
options for
men with advanced, metastatic prostate cancer.
...
FDA Approves GlaxoSmithKline's AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
... prostate, a disease that affects half of
all
men over 50 years old. The new indication reflects ... one of the largest clinical
trials to date of
men with enlarged prostate. The CombAT study is the ... double-blind and parallel-group
study.
men [aged greater than or equal to 50 years with a ...
Growing Generations Announces Surrogacy Program for Men with HIV
... provides
surrogacy and egg donation services to
men with HIV and allows them to use
their own sperm ... The company already has
five cases of
men with HIV working with egg donors and surrogates, ... and
preparation process for the sperm. Many
men with HIV show no material trace
of the virus in ...
AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal
... 3 trials which will
include approximately 1,500
men with symptomatic BPH in the United States,
Canada ... (BPH) is one of the most common diseases
of aging
men - affecting more than 20 million
men in the United States -
but its etiology is far ...
When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer
... the first systematic surveillance program of
men with prostate
cancer to look for biological clues ... of six institutions nationwide will enroll
men in a
cancer-surveillance study to look for ... or "watchful waiting." For most
men with prostate cancer, the
disease never ...
FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA
... Prostate cancer is the most common cancer in
men in the U.S., excluding
skin cancer, and is ... to be diagnosed in 2008
in the U.S.; 28,660
men with prostate cancer are expected to die this
year(1). The majority of cases diagnosed are in
men over the age of 65.
Prostate cancer can be ...
AEterna Zentaris: Lead Investigator for Cetrorelix Trials in BPH Wins Best Poster Presentation Award at European Association of Urology Meeting in Milan
... convenient and safe treatment for the millions
of
men with BPH."
THE POSTER
Introduction and ... 3 trials which will
include approximately 1,500
men with symptomatic BPH in the United States,
Canada ... (BPH) is one of the most common diseases
of aging
men - affecting more than 20 ...
AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
... 3 trials which will
include approximately 1,500
men with symptomatic BPH in the United States,
Canada ... (BPH) is one of the most common diseases
of aging
men - affecting more than 20 million
men in the United States -
but its etiology is far ...
Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded
... to offering new recovery options
for the brave
men and women who have served our country," Dr. ... the impact of combat
injuries on the fine
men and women of our Armed Forces," Dr. Cosgrove ... blast injuries and to enable our injured
men and women to
return to productive lives," Dr. ...
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
... as possible to enable us to bring PROVENGE to the
men in
need of a new treatment option."
Conference ... 3 study, which enrolled just over 500
men with metastatic, androgen
independent prostate ... common cancer worldwide. More than one million
men in
the United States have prostate cancer, with ...
Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
... cause of death in the United States
for both
men and women. Lifestyle changes, medicines, and/or ... risk. While women are four times more likely
than
men to develop the disease,
men also suffer from osteoporosis.
About Skin Care ...
Barr Launches Generic Fosamax(R) Tablets, 70 mg
... women; for the treatment to
increase bone mass in
men with osteoporosis; for the treatment of
glucocorticoid-induced osteoporosis in
men and women receiving
glucocorticoids in a daily ... for the treatment of
Paget's disease of bone in
men and women.
Fosamax Tablets, 70 mg had annual ...
Of mice and men: new male contraceptives successful in rodents and humans
... none of them quite perfect. But what if
men want to help out? They have only two options -- ... but get old in long-term relationships. Will
men ever have a way to reliably make sure that nobody ... pundits have predicted new contraceptives for
men within the next 5 to 10 years. But judging from ...
Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
... compound in development for the
treatment of
men with hormone resistant prostate cancer (HRPC), ... these therapies can provide great benefits, most
men will
become resistant to them. Currently, the ... patients shown to improve survival in
men with HRPC is
chemotherapy with docetaxel." "The ...
OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
... positions the availability of OGX-011 treatment to a larger number of
men with prostate cancer."
The Phase 3 trial has been designed in ... revised trial will be a randomized, controlled, international study in 800
men with metastatic CRPC who are in need of first-line chemotherapy. Patients ...
Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August
... at Amgen. "Likewise, there is currently no approved treatment for the
men and women receiving hormone ablation therapy for prostate or breast cancer ... Bone Loss
In the U.S., prostate cancer is the most common cancer in
men and breast cancer is the most common cancer in women. It is common for ...
Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
... placebo-controlled, multi-center, phase III trial of sipuleucel-T in
men with metastatic, androgen independent prostatic adenocarcinoma (AIPC)." ... (sipuleucel-T), Dendreon's investigational product candidate for
men with advanced prostate cancer representing the first in a new class of ...
Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
... active cellular immunotherapy PROVENGE(R) (sipuleucel-T) in
men with androgen-independent prostate cancer. While Dendreon remains blinded ... to risks and uncertainties surrounding the efficacy of PROVENGE to treat
men suffering from prostate cancer, risks and uncertainties surrounding the ...
OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
... in combination with docetaxel as second-line chemotherapy
in
men with CRPC, via the SPA process. In a letter from the FDA
... in combination with
docetaxel as second-line chemotherapy in
men with CRPC. OncoGenex has
revised the protocol based on the FDA's ...
While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas
... enhancement, to university teaching programs, and even to helping put
men on Mars.
It also launched--and quickly closed--an outside funding ... of that industry strength than being called upon to help NASA put
men on Mars?
LMI's software is integral to the space agency's ...
China Sky One Medical, Inc. Receives Scientific Achievement Award
... Dispersible Tablets are intended for the treatment of enlarged
prostate in
men and can be easily absorbed and digested by the human body. Jin
Chuang has ... there is a huge potential market
for drugs that treat enlarged prostate in
men and we forecast that the sales
of Naftopidil Dispersible Tablets will help ...
Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting
...
Colorectal cancer is the third most common cancer diagnosed in
men and in women in the United States (U.S.). The American Cancer Society ... 2008. Colorectal cancer is the second leading cause of cancer death among
men and women in the U.S. and it has been estimated that more than 49,000 ...
Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
... Development
-- Results From NEBIDO Phase III Trial Shows 94 Percent of
men Maintained
Normal Testosterone Levels Throughout Treatment
-- ... for the treatment
of male hypogonadism. DELATESTRYL is contraindicated in
men with carcinomas of
the breast or with known, or suspected, carcinomas of ...